verapamil has been researched along with Hyperlipidemias in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further studies in humans are required to determine whether modification of the oral verapamil dosage regimen in HL states is necessary." | 1.38 | Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407. ( Kang, HE; Lee, MG; Lee, YS; Yoon, IS; Yoon, JN, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YS | 1 |
| Yoon, JN | 1 |
| Yoon, IS | 1 |
| Lee, MG | 1 |
| Kang, HE | 1 |
| Oganov, RG | 1 |
| Lepakhin, VK | 1 |
| Fitilev, SB | 1 |
| Levin, AM | 1 |
| Titarova, YY | 1 |
| Sytchev, EN | 1 |
| Tilton, GD | 1 |
| Buja, LM | 1 |
| Bilheimer, DW | 1 |
| Apprill, P | 1 |
| Ashton, J | 1 |
| McNatt, J | 1 |
| Kita, T | 1 |
| Willerson, JT | 1 |
3 other studies available for verapamil and Hyperlipidemias
| Article | Year |
|---|---|
Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407.
Topics: Administration, Oral; Animals; Blood Proteins; Hyperlipidemias; Infusions, Intravenous; Male; Micros | 2012 |
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens | 2003 |
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Disease Models, Animal; Female; Hyperlipidemias | 1985 |